Title: Incidence and predictors of elevated postpartum alanine aminotransferase in chronic
hepatitis B mothers: A prospective study protocol
Version: 5 Date: 14 Aug 2023
Reviewer's report:
Thank you for your well-clarified point-by-point response.  There is no significant comment for
the revised protocol, except a few questions about
1. the definition of ALT flare in the postpartum period.
2. If healthy mothers develop a significant illness during their late pregnancy for example
developing preeclampsia, does the investigator plan to remove those subjects from the study?
Title: Incidence and predictors of elevated postpartum alanine aminotransferase in chronic
hepatitis B mothers: A prospective study protocol
Version: 5 Date: 14 Aug 2023
Reviewer's report:
Thank you for your well-clarified point-by-point response.  There is no significant comment for
the revised protocol, except a few questions about
1. the definition of ALT flare in the postpartum period.
2. If healthy mothers develop a significant illness during their late pregnancy for example
developing preeclampsia, does the investigator plan to remove those subjects from the study?
Please review this paper.
user
Title: Incidence and predictors of elevated postpartum alanine aminotransferase in chronic
hepatitis B mothers: A prospective study protocol
Version: 5 Date: 14 Aug 2023
Reviewer's report:
Thank you for your well-clarified point-by-point response.  There is no significant comment for
the revised protocol, except a few questions about
1. the definition of ALT flare in the postpartum period.
2. If healthy mothers develop a significant illness during their late pregnancy for example
developing preeclampsia, does the investigator plan to remove those subjects from the study?
assistant